Loading...
Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
Lung cancers with epidermal growth factor receptor (EGFR) gene mutation account for ∼40% of adenocarcinoma in East Asians and ∼15% of that in Caucasians, which makes them one of the most common molecularly defined lung cancer subsets. The role of EGFR mutation as a strong predictive biomarker of res...
Saved in:
| Published in: | Lung Cancer (Auckl) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217442/ https://ncbi.nlm.nih.gov/pubmed/28210134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S49603 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|